{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,9]],"date-time":"2026-11-09T17:22:59Z","timestamp":1794244979699,"version":"4.9.0"},"reference-count":42,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001869","name":"Academia Sinica","doi-asserted-by":"publisher","award":["AS-iMATE-107-97"],"award-info":[{"award-number":["AS-iMATE-107-97"]}],"id":[{"id":"10.13039\/501100001869","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2023,2]]},"DOI":"10.1016\/j.jconrel.2022.12.039","type":"journal-article","created":{"date-parts":[[2023,1,13]],"date-time":"2023-01-13T17:00:03Z","timestamp":1673629203000},"page":"316-322","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":85,"special_numbering":"C","title":["Anti-PEG antibodies before and after a first dose of Comirnaty\u00ae (mRNA-LNP-based SARS-CoV-2 vaccine)"],"prefix":"10.1016","volume":"354","author":[{"given":"Yaelle","family":"Bavli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bing-Mae","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guy","family":"Gross","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alon","family":"Hershko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keren","family":"Turjeman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steve","family":"Roffler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yechezkel","family":"Barenholz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jconrel.2022.12.039_bb0005","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1016\/S0140-6736(21)02796-3","article-title":"Estimating excess mortality due to the COVID-19 pandemic: a systematic analysis of COVID-19-related mortality, 2020-21","volume":"399","author":"Wang","year":"2022","journal-title":"Lancet (Lond. England)"},{"key":"10.1016\/j.jconrel.2022.12.039_bb0010","doi-asserted-by":"crossref","DOI":"10.1016\/S1473-3099(22)00320-6","article-title":"Global impact of the first year of COVID-19 vaccination: a mathematical modelling study","author":"Watson","year":"2022","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.jconrel.2022.12.039_bb0015","doi-asserted-by":"crossref","first-page":"2560","DOI":"10.1021\/la0479105","article-title":"Electrostatics of PEGylated micelles and liposomes containing charged and neutral lipopolymers","volume":"21","author":"Garbuzenko","year":"2005","journal-title":"Langmuir."},{"key":"10.1016\/j.jconrel.2022.12.039_bb0020","doi-asserted-by":"crossref","first-page":"21733","DOI":"10.1039\/C9NR09347H","article-title":"On the role of helper lipids in lipid nanoparticle formulations of siRNA","volume":"11","author":"Kulkarni","year":"2019","journal-title":"Nanoscale."},{"key":"10.1016\/j.jconrel.2022.12.039_bb0025","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1016\/S0006-3495(98)77849-X","article-title":"Hydration of polyethylene glycol-grafted liposomes","volume":"74","author":"Tirosh","year":"1998","journal-title":"Biophys. J."},{"key":"10.1016\/j.jconrel.2022.12.039_bb0030","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.chemphyslip.2005.02.003","article-title":"Effect of grafted PEG on liposome size and on compressibility and packing of lipid bilayer","volume":"135","author":"Garbuzenko","year":"2005","journal-title":"Chem. Phys. Lipids"},{"key":"10.1016\/j.jconrel.2022.12.039_bb0035","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1021\/la0110085","article-title":"Determination of critical micelle concentration of lipopolymers and other amphiphiles: Comparison of sound velocity and fluorescent measurements","volume":"18","author":"Priev","year":"2002","journal-title":"Langmuir."},{"key":"10.1016\/j.jconrel.2022.12.039_bb0040","doi-asserted-by":"crossref","DOI":"10.1038\/mtna.2013.66","article-title":"Influence of polyethylene glycol lipid desorption rates on pharmacokinetics and pharmacodynamics of siRNA lipid nanoparticles","volume":"2","author":"Mui","year":"2013","journal-title":"Mol. Ther. Nucl. Acids"},{"key":"10.1016\/j.jconrel.2022.12.039_bb0045","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1002\/cncr.22739","article-title":"Antibody against poly(ethylene glycol) adversely affects PEG-asparaginase therapy in acute lymphoblastic leukemia patients","volume":"110","author":"Armstrong","year":"2007","journal-title":"Cancer."},{"key":"10.1016\/j.jconrel.2022.12.039_bb0050","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1002\/art.22403","article-title":"Pharmacokinetics and pharmacodynamics of intravenous PEGylated recombinant mammalian urate oxidase in patients with refractory gout","volume":"56","author":"Sundy","year":"2007","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jconrel.2022.12.039_bb0055","doi-asserted-by":"crossref","first-page":"R63","DOI":"10.1186\/ar4500","article-title":"Induced and pre-existing anti-polyethylene glycol antibody in a trial of every 3-week dosing of pegloticase for refractory gout, including in organ transplant recipients","volume":"16","author":"Hershfield","year":"2014","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.jconrel.2022.12.039_bb0060","doi-asserted-by":"crossref","first-page":"10661","DOI":"10.1021\/acs.analchem.6b03109","article-title":"Measurement of pre-existing IgG and IgM antibodies against polyethylene glycol in healthy individuals","volume":"88","author":"Chen","year":"2016","journal-title":"Anal. Chem."},{"key":"10.1016\/j.jconrel.2022.12.039_bb0065","series-title":"Transfusion","article-title":"Normal donor sera can contain antibodies to polyethylene glycol (PEG)","author":"Leger","year":"2001"},{"key":"10.1016\/j.jconrel.2022.12.039_bb0070","series-title":"Blood","article-title":"Occurrence of an antibody to poly (ethylene glycol) in normal donors","author":"Armstrong","year":"2003"},{"key":"10.1016\/j.jconrel.2022.12.039_bb0075","doi-asserted-by":"crossref","first-page":"S129","DOI":"10.1016\/S0168-8278(10)60309-1","article-title":"307 High prevalence of pre-existing antibodies angainst polyethylene glycol (PEG) in hepatitic C (HCV) patients which is not associated with impaired response to PEG-interferon","volume":"52","author":"Tillmann","year":"2010","journal-title":"J. Hepatol."},{"key":"10.1016\/j.jconrel.2022.12.039_bb0080","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1002\/wnan.1339","article-title":"Anti-PEG immunity: emergence, characteristics, and unaddressed questions","volume":"7","author":"Yang","year":"2015","journal-title":"Wiley Interdiscip. Rev. Nanomed. Nanobiotechnol."},{"key":"10.1016\/j.jconrel.2022.12.039_bb0085","doi-asserted-by":"crossref","first-page":"14022","DOI":"10.1021\/acsnano.1c05922","article-title":"Polyethylene glycol immunogenicity: theoretical, clinical, and practical aspects of anti-polyethylene glycol antibodies","volume":"15","author":"Chen","year":"2021","journal-title":"ACS Nano"},{"key":"10.1016\/j.jconrel.2022.12.039_bb0090","doi-asserted-by":"crossref","first-page":"7808","DOI":"10.1021\/acsnano.9b07218","article-title":"Premature drug release from polyethylene glycol (PEG)-coated liposomal doxorubicin via formation of the membrane attack complex","volume":"14","author":"Chen","year":"2020","journal-title":"ACS Nano"},{"key":"10.1016\/j.jconrel.2022.12.039_bb0095","first-page":"18","article-title":"Roadmap and strategy for overcoming infusion reactions to nanomedicines","volume":"22","author":"Szebeni","year":"2018","journal-title":"Nat. Nanotechnol."},{"key":"10.1016\/j.jconrel.2022.12.039_bb0100","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1038\/s41565-022-01071-x","article-title":"Applying lessons learned from nanomedicines to understand rare hypersensitivity reactions to mRNA-based SARS-CoV-2 vaccines","volume":"17","author":"Szebeni","year":"2022","journal-title":"Nat. Nanotechnol."},{"key":"10.1016\/j.jconrel.2022.12.039_bb0105","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaip.2022.07.012","article-title":"Reporting of allergic reactions during Pfizer-BioNTech BNTT162B2 vaccination in Israel","author":"Anis","year":"2022","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jconrel.2022.12.039_bb0110","doi-asserted-by":"crossref","first-page":"11769","DOI":"10.1021\/acsnano.2c04543","article-title":"Anti-PEG antibodies boosted in humans by SARS-CoV-2 lipid nanoparticle mRNA vaccine","volume":"16","author":"Ju","year":"2022","journal-title":"ACS Nano"},{"key":"10.1016\/j.jconrel.2022.12.039_bb0115","first-page":"129849","article-title":"Effect of the ammonium salt anion on the structure of doxorubicin complex and PEGylated liposomal doxorubicin nanodrugs","volume":"2021","author":"Schilt","year":"1865","journal-title":"Biochim. Biophys. Acta Gen. Subj."},{"key":"10.1016\/j.jconrel.2022.12.039_bb0120","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1021\/bc050133f","article-title":"Monoclonal antibody-based quantitation of poly(ethylene glycol)-derivatized proteins, liposomes, and nanoparticles","volume":"16","author":"Cheng","year":"2005","journal-title":"Bioconjug. Chem."},{"key":"10.1016\/j.jconrel.2022.12.039_bb0125","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1021\/bc100067t","article-title":"Sensitive quantification of PEGylated compounds by second-generation anti-poly(ethylene glycol) monoclonal antibodies","volume":"21","author":"Su","year":"2010","journal-title":"Bioconjug. Chem."},{"key":"10.1016\/j.jconrel.2022.12.039_bb0130","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms15507","article-title":"Conditional internalization of PEGylated nanomedicines by PEG engagers for triple negative breast cancer therapy","volume":"8","author":"Su","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jconrel.2022.12.039_bb0135","series-title":"PEGylated Liposomal Methyl Prednisolone Succinate does not Induce Infusion Reactions in Patients: A Correlation Between in Vitro Immunological and in Vivo Clinical Studies, Mol","volume":"25","author":"Bavli","year":"2020"},{"key":"10.1016\/j.jconrel.2022.12.039_bb0140","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0130442","article-title":"Nano-drugs based on nano sterically stabilized liposomes for the treatment of inflammatory neurodegenerative diseases","volume":"10","author":"Turjeman","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.jconrel.2022.12.039_bb0145","doi-asserted-by":"crossref","DOI":"10.3390\/vaccines9090974","article-title":"Pseudo-anaphylactic reactions to pfizer bnt162b2 vaccine: report of 3 cases of anaphylaxis post pfizer bnt162b2 vaccination","volume":"9","author":"Lim","year":"2021","journal-title":"Vaccines"},{"key":"10.1016\/j.jconrel.2022.12.039_bb0150","first-page":"E3351","article-title":"Successful reprogramming of cellular protein production through mRNA delivered by functionalized lipid nanoparticles","volume":"115","author":"Arteta","year":"2018","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jconrel.2022.12.039_bb0155","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1007\/s40883-021-00198-y","article-title":"clinical relevance of pre-existing and treatment-induced anti-poly(ethylene glycol) antibodies","volume":"8","author":"Freire Haddad","year":"2022","journal-title":"Regen. Eng. Transl. Med."},{"key":"10.1016\/j.jconrel.2022.12.039_bb0160","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1517\/17425247.2012.720969","article-title":"Antibodies against polyethylene glycol in healthy subjects and in patients treated with PEG-conjugated agents","volume":"9","author":"Garay","year":"2012","journal-title":"Expert Opin. Drug Deliv."},{"key":"10.1016\/j.jconrel.2022.12.039_bb0165","doi-asserted-by":"crossref","first-page":"11804","DOI":"10.1021\/acs.analchem.6b03437","article-title":"Analysis of pre-existing IgG and IgM antibodies against polyethylene glycol (PEG) in the general population","volume":"88","author":"Yang","year":"2016","journal-title":"Anal. Chem."},{"key":"10.1016\/j.jconrel.2022.12.039_bb0170","doi-asserted-by":"crossref","first-page":"2239","DOI":"10.1007\/s11095-016-1961-x","article-title":"The mystery of antibodies against polyethylene glycol (PEG) - what do we know?","volume":"33","author":"Lubich","year":"2016","journal-title":"Pharm. Res."},{"key":"10.1016\/j.jconrel.2022.12.039_bb0175","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaci.2005.11.016","article-title":"5. IgE, mast cells, basophils, and eosinophils","volume":"117","author":"Prussin","year":"2006","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.jconrel.2022.12.039_bb0180","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.nano.2011.06.003","article-title":"Liposome-induced complement activation and related cardiopulmonary distress in pigs: factors promoting reactogenicity of Doxil and AmBisome","volume":"8","author":"Szebeni","year":"2012","journal-title":"Nanomedicine."},{"key":"10.1016\/j.jconrel.2022.12.039_bb0185","doi-asserted-by":"crossref","first-page":"6114","DOI":"10.1016\/j.vaccine.2022.08.024","article-title":"mRNA-1273 but not BNT162b2 induces antibodies against polyethylene glycol (PEG) contained in mRNA-based vaccine formulations","volume":"40","author":"Carre\u00f1o","year":"2022","journal-title":"Vaccine"},{"key":"10.1016\/j.jconrel.2022.12.039_bb0190","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23168838","article-title":"Monitoring anti-PEG antibodies level upon repeated lipid nanoparticle-based COVID-19 vaccine administration","volume":"23","author":"Guerrini","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jconrel.2022.12.039_bb0195","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1038\/s41591-020-0897-1","article-title":"Antibody responses to SARS-CoV-2 in patients with COVID-19","volume":"26","author":"Long","year":"2020","journal-title":"Nat. Med."},{"key":"10.1016\/j.jconrel.2022.12.039_bb0200","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2022.103888","article-title":"SARS-CoV-2 vaccination elicits unconventional IgM specific responses in na\u00efve and previously COVID-19-infected individuals","volume":"77","author":"Ruggiero","year":"2022","journal-title":"EBioMedicine"},{"key":"10.1016\/j.jconrel.2022.12.039_bb0205","doi-asserted-by":"crossref","first-page":"1700","DOI":"10.3390\/molecules23071700","article-title":"Understanding the role of anti-PEG antibodies in the complement activation by Doxil in vitro","volume":"23","author":"Neun","year":"2018","journal-title":"Molecules."},{"key":"10.1016\/j.jconrel.2022.12.039_bb0210","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/j.jconrel.2021.11.042","article-title":"Anti-PEG antibodies compromise the integrity of PEGylated lipid-based nanoparticles via complement","volume":"341","author":"Estap\u00e9 Senti","year":"2022","journal-title":"J. Control. Release Off. J. Control. Release Soc."}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365922008537?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365922008537?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T16:36:28Z","timestamp":1759163788000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168365922008537"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2]]},"references-count":42,"alternative-id":["S0168365922008537"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2022.12.039","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2023,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Anti-PEG antibodies before and after a first dose of Comirnaty\u00ae (mRNA-LNP-based SARS-CoV-2 vaccine)","name":"articletitle","label":"Article Title"},{"value":"Journal of Controlled Release","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jconrel.2022.12.039","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}